organ transplant
Oncocyte Q1 Revenues Rise 27 Percent on DetermaRx Activity
The Irvine, California-based diagnostics firm reported $1.4 million in revenue, missing the consensus Wall Street estimate of $2.2 million.
Hologic Nabs FDA Approval for Quantitative Cytomegalovirus Test
The test runs on Hologic's Panther system and is intended to be used for post-transplant pathogen detection and monitoring.
Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure.
Post-Transplant Diabetes Risk Informed by Polygenic Risk Profiles in Donors, Recipients
Along with insights from recipient risk scores, researchers found that liver donors' type 2 diabetes PRS was associated with post-transplant diabetes mellitus in recipients.
CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients
The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure.